Use of uterine vessel occlusion in the management of uterine myomas

Two different approaches

Wen Ling Lee, Wei Min Liu, Jong Ling Fuh, Ying Chieh Tsai, Chun Che Shih, Peng Hui Wang

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To evaluate the difference between uterine artery occlusion alone (UAO) and combined (UVO) with simultaneous blockage of anastomosis between the uterine and ovarian vessels in the management of women with myomas in a 3-year follow-up. Design: Case-control study. Setting: University-associated hospital. Patient(s): One hundred ten patients with uterine fibroids. Intervention(s): Forty-four patients underwent UAO and 66 patients UVO; patients were matched using a statistically generated selection of all UVOs performed during the same period. Main Outcome Measure(s): Outcomes were assessed by comparing surgical parameters, immediate postoperative recovery, and therapeutic outcomes. Result(s): During the 3-year follow-up, the majority of patients in both groups reported symptom relief (ranging from 61.5% to 84.6% in the UVO group and 31.6% to 77.3% in the UAO group, on the basis of different kinds of symptoms). However, symptom control seemed to be different between the two groups when the follow-up time was prolonged; for example, symptom control was better in the UVO group at the end of 3 years, especially for menorrhagia (76.5% vs. 34.5%). The fibroid size was smaller in the UVO group, resulting in a lower reintervention rate, compared with the UAO group (13.6% vs. 36.4%). Conclusion(s): If UVO is used for uterine fibroids, the 3-year efficacy might be better than that with UAO. This finding is worthy of further investigation.

Original languageEnglish
Pages (from-to)1875-1881
Number of pages7
JournalFertility and Sterility
Volume94
Issue number5
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Myoma
Uterine Artery
Leiomyoma
Menorrhagia
Case-Control Studies
Outcome Assessment (Health Care)

Keywords

  • efficacy
  • fibroids
  • Laparoscopic uterine vessel occlusion
  • myoma

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine
  • Medicine(all)

Cite this

Use of uterine vessel occlusion in the management of uterine myomas : Two different approaches. / Lee, Wen Ling; Liu, Wei Min; Fuh, Jong Ling; Tsai, Ying Chieh; Shih, Chun Che; Wang, Peng Hui.

In: Fertility and Sterility, Vol. 94, No. 5, 10.2010, p. 1875-1881.

Research output: Contribution to journalArticle

Lee, Wen Ling ; Liu, Wei Min ; Fuh, Jong Ling ; Tsai, Ying Chieh ; Shih, Chun Che ; Wang, Peng Hui. / Use of uterine vessel occlusion in the management of uterine myomas : Two different approaches. In: Fertility and Sterility. 2010 ; Vol. 94, No. 5. pp. 1875-1881.
@article{27b4aa48c4434d61b0ae54548643088f,
title = "Use of uterine vessel occlusion in the management of uterine myomas: Two different approaches",
abstract = "Objective: To evaluate the difference between uterine artery occlusion alone (UAO) and combined (UVO) with simultaneous blockage of anastomosis between the uterine and ovarian vessels in the management of women with myomas in a 3-year follow-up. Design: Case-control study. Setting: University-associated hospital. Patient(s): One hundred ten patients with uterine fibroids. Intervention(s): Forty-four patients underwent UAO and 66 patients UVO; patients were matched using a statistically generated selection of all UVOs performed during the same period. Main Outcome Measure(s): Outcomes were assessed by comparing surgical parameters, immediate postoperative recovery, and therapeutic outcomes. Result(s): During the 3-year follow-up, the majority of patients in both groups reported symptom relief (ranging from 61.5{\%} to 84.6{\%} in the UVO group and 31.6{\%} to 77.3{\%} in the UAO group, on the basis of different kinds of symptoms). However, symptom control seemed to be different between the two groups when the follow-up time was prolonged; for example, symptom control was better in the UVO group at the end of 3 years, especially for menorrhagia (76.5{\%} vs. 34.5{\%}). The fibroid size was smaller in the UVO group, resulting in a lower reintervention rate, compared with the UAO group (13.6{\%} vs. 36.4{\%}). Conclusion(s): If UVO is used for uterine fibroids, the 3-year efficacy might be better than that with UAO. This finding is worthy of further investigation.",
keywords = "efficacy, fibroids, Laparoscopic uterine vessel occlusion, myoma",
author = "Lee, {Wen Ling} and Liu, {Wei Min} and Fuh, {Jong Ling} and Tsai, {Ying Chieh} and Shih, {Chun Che} and Wang, {Peng Hui}",
year = "2010",
month = "10",
doi = "10.1016/j.fertnstert.2009.11.015",
language = "English",
volume = "94",
pages = "1875--1881",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Use of uterine vessel occlusion in the management of uterine myomas

T2 - Two different approaches

AU - Lee, Wen Ling

AU - Liu, Wei Min

AU - Fuh, Jong Ling

AU - Tsai, Ying Chieh

AU - Shih, Chun Che

AU - Wang, Peng Hui

PY - 2010/10

Y1 - 2010/10

N2 - Objective: To evaluate the difference between uterine artery occlusion alone (UAO) and combined (UVO) with simultaneous blockage of anastomosis between the uterine and ovarian vessels in the management of women with myomas in a 3-year follow-up. Design: Case-control study. Setting: University-associated hospital. Patient(s): One hundred ten patients with uterine fibroids. Intervention(s): Forty-four patients underwent UAO and 66 patients UVO; patients were matched using a statistically generated selection of all UVOs performed during the same period. Main Outcome Measure(s): Outcomes were assessed by comparing surgical parameters, immediate postoperative recovery, and therapeutic outcomes. Result(s): During the 3-year follow-up, the majority of patients in both groups reported symptom relief (ranging from 61.5% to 84.6% in the UVO group and 31.6% to 77.3% in the UAO group, on the basis of different kinds of symptoms). However, symptom control seemed to be different between the two groups when the follow-up time was prolonged; for example, symptom control was better in the UVO group at the end of 3 years, especially for menorrhagia (76.5% vs. 34.5%). The fibroid size was smaller in the UVO group, resulting in a lower reintervention rate, compared with the UAO group (13.6% vs. 36.4%). Conclusion(s): If UVO is used for uterine fibroids, the 3-year efficacy might be better than that with UAO. This finding is worthy of further investigation.

AB - Objective: To evaluate the difference between uterine artery occlusion alone (UAO) and combined (UVO) with simultaneous blockage of anastomosis between the uterine and ovarian vessels in the management of women with myomas in a 3-year follow-up. Design: Case-control study. Setting: University-associated hospital. Patient(s): One hundred ten patients with uterine fibroids. Intervention(s): Forty-four patients underwent UAO and 66 patients UVO; patients were matched using a statistically generated selection of all UVOs performed during the same period. Main Outcome Measure(s): Outcomes were assessed by comparing surgical parameters, immediate postoperative recovery, and therapeutic outcomes. Result(s): During the 3-year follow-up, the majority of patients in both groups reported symptom relief (ranging from 61.5% to 84.6% in the UVO group and 31.6% to 77.3% in the UAO group, on the basis of different kinds of symptoms). However, symptom control seemed to be different between the two groups when the follow-up time was prolonged; for example, symptom control was better in the UVO group at the end of 3 years, especially for menorrhagia (76.5% vs. 34.5%). The fibroid size was smaller in the UVO group, resulting in a lower reintervention rate, compared with the UAO group (13.6% vs. 36.4%). Conclusion(s): If UVO is used for uterine fibroids, the 3-year efficacy might be better than that with UAO. This finding is worthy of further investigation.

KW - efficacy

KW - fibroids

KW - Laparoscopic uterine vessel occlusion

KW - myoma

UR - http://www.scopus.com/inward/record.url?scp=77957191248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957191248&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2009.11.015

DO - 10.1016/j.fertnstert.2009.11.015

M3 - Article

VL - 94

SP - 1875

EP - 1881

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -